Morimatsu (China) Investments, a wholly-owned subsidiary of Morimatsu International Holdings Co. Ltd., has been actively engaged in investment holding business within the People's Republic of China. The company recently participated in a significant transaction involving the Target Company, a non-wholly owned subsidiary. The Target Company, known for serving industries such as pharmaceuticals, biopharmaceuticals, and fast-moving consumer goods, is set to receive an additional registered capital of RMB12,946,412. This capital infusion, amounting to RMB330,000,000, was agreed upon through a transaction with investors, highlighting Morimatsu (China) Investments' ongoing commitment to supporting its subsidiaries in expanding their industry presence and capabilities.